Logo image of EXEL

EXELIXIS INC (EXEL) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:EXEL - US30161Q1040 - Common Stock

46.19 USD
+2.51 (+5.75%)
Last: 1/7/2026, 8:00:02 PM
46.19 USD
0 (0%)
After Hours: 1/7/2026, 8:00:02 PM
Buy % Consensus

76

ChartMill assigns a Buy % Consensus number of 76% to EXEL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 46.18. This target is -0.01% below the current price.
EXEL was analyzed by 27 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about EXEL.
In the previous month the buy percentage consensus was at a similar level.
EXEL was analyzed by 27 analysts, which is quite many. So the average rating should be quite meaningful.
EXEL Historical Analyst RatingsEXEL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -108 -98 -88 -78 -68 -58 -48 -38 -28 -18 -8 5 10 15 20 25

Price Target & Forecast

Price Low Median Mean High 46.1930.3046.4146.1863.00 - -34.40% 0.48% -0.01% 36.39%
EXEL Current Analyst RatingEXEL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-11-06 UBS Maintains Neutral -> Neutral
2025-11-05 TD Cowen Maintains Buy -> Buy
2025-11-05 Barclays Maintains Equal-Weight -> Equal-Weight
2025-11-05 Morgan Stanley Maintains Overweight -> Overweight
2025-11-05 HC Wainwright & Co. Maintains Buy -> Buy
2025-11-03 Guggenheim Downgrade Buy -> Neutral
2025-10-21 Leerink Partners Upgrade Market Perform -> Outperform
2025-10-21 RBC Capital Reiterate Sector Perform -> Sector Perform
2025-10-21 Wells Fargo Maintains Equal-Weight -> Equal-Weight
2025-10-21 Morgan Stanley Maintains Overweight -> Overweight
2025-09-17 Barclays Initiate Equal-Weight
2025-09-17 Goldman Sachs Initiate Buy
2025-09-17 Morgan Stanley Maintains Overweight -> Overweight
2025-08-12 HC Wainwright & Co. Maintains Buy -> Buy
2025-07-30 UBS Maintains Neutral -> Neutral
2025-07-29 Guggenheim Reiterate Buy -> Buy
2025-07-29 JMP Securities Reiterate Market Outperform -> Market Outperform
2025-07-29 RBC Capital Maintains Sector Perform -> Sector Perform
2025-07-29 Stifel Maintains Hold -> Hold
2025-07-29 Truist Securities Maintains Buy -> Buy
2025-07-29 Morgan Stanley Maintains Overweight -> Overweight
2025-07-22 Morgan Stanley Maintains Overweight -> Overweight
2025-07-15 Truist Securities Maintains Buy -> Buy
2025-07-10 Barclays Maintains Equal-Weight -> Equal-Weight
2025-06-30 HC Wainwright & Co. Maintains Buy -> Buy
2025-06-24 Stephens & Co. Upgrade Equal-Weight -> Overweight
2025-06-23 JMP Securities Maintains Market Outperform -> Market Outperform
2025-06-23 Truist Securities Reiterate Buy -> Buy
2025-06-12 HC Wainwright & Co. Maintains Buy -> Buy
2025-06-05 B of A Securities Maintains Neutral -> Neutral

EXELIXIS INC / EXEL FAQ

Can you provide the average price target for EXELIXIS INC stock?

27 analysts have analysed EXEL and the average price target is 46.18 USD. This implies a price decrease of -0.01% is expected in the next year compared to the current price of 46.19.


How do analysts rate EXELIXIS INC (EXEL)?

The consensus rating for EXELIXIS INC (EXEL) is 76.2963 / 100 . This indicates that analysts generally have a positive outlook on the stock.


What is the number of analysts for EXEL stock?

The number of analysts covering EXELIXIS INC (EXEL) is 27.